Sponsored by:

Nuclear Medicine: Page 414

Mobile PET adds 10 contracts
By AuntMinnie.com staff writers
Mobile PET Systems has signed ten contracts for its mobile PET services.
November 19, 2001
Bristol-Myers-Squibb, Amersham Health share patent rights
By AuntMinnie.com staff writers
Bristol-Myers Squibb Medical Imaging and Amersham Health have signed several strategic agreements involving ultrasound contrast and nuclear medicine.
November 14, 2001
Siemens installs first Biograph system
By AuntMinnie.com staff writers
The nuclear medicine group of Siemens Medical Solutions of Hoffman Estates, IL, has completed the first commercial installation of its Biograph hybrid CT/PET system.
November 14, 2001
Draxis gets NRC approval for BrachySeed Pd-103
By AuntMinnie.com staff writers
Radiopharmaceutical manufacturer DraxImage has received final approval from the U.S. Nuclear Regulatory Commission for the palladium version of its BrachySeed brachytherapy implant.
November 12, 2001
Positron revenues slip
By AuntMinnie.com staff writers
PET manufacturer Positron reported third-quarter revenues of $356,000, down sharply from the $3.4 million posted in the third quarter of 2000.
November 11, 2001
Palatin raises $11 million
By AuntMinnie.com staff writers
Radiopharmaceutical developer Palatin Technologies has added $11 million to its war chest in a stock offering to a group of investment firms.
November 11, 2001
Draxis revenues climb
By AuntMinnie.com staff writers
Draxis Health reported third-quarter revenues of $9.7 million, up 20% compared with the $8 million reported last year. For the quarter (end-September 30), the Mississauga, Ontario-based firm had net income of $259,000, compared with a net loss of $421,000 in the third quarter of 2000.
November 7, 2001
Neoprobe revenue drops in third quarter
By AuntMinnie.com staff writers
Gamma-detection-system maker Neoprobe reported third-quarter revenue of $1.8 million, compared to $2.8 million for the same period a year earlier. Neoprobe had net income for the quarter (end-September 30) of $401,000 compared to $504,000 for the same period last year.
November 4, 2001
PET beats CT for staging, restaging, and managing NSCLC
By Eric Barnes
As FDG-PET enters the mainstream of clinical oncology, it is proving to be particularly adept in the nuts and bolts of staging and disease management. In two studies that evaluated the use of PET in non-small cell lung cancer, Australian researchers said the technique offers "powerful prognostic stratification" that is highly appropriate to therapeutic needs.
November 4, 2001
2001 11 02 16 46 36 706
P.E.T. Net to operate Wake Forest FDG facility
By AuntMinnie.com staff writers
P.E.T. Net Pharmaceuticals of Knoxville, TN, will operate the Wake Forest University Baptist Medical Center’s radiopharmaceutical production facility in Winston-Salem, NC.
October 31, 2001
Immunomedics licenses labeling method
By AuntMinnie.com staff writers
Immunomedics has licensed its proprietary method of labeling antibodies with technetium-99m (Tc-99m) to Agen Biomedical, and is looking for other licensing opportunities.
October 28, 2001
Syncor reports 25% operating income increase
By AuntMinnie.com staff writers
Radiopharmacy firm Syncor International reported a 25% increase in third-quarter operating income, to $15.4 million, up from $12.3 million for the same period last year.
October 24, 2001
Previous Page
Page 414 of 440
Next Page